Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
12 Apr 2022
12 Apr 2022
Historique:
pubmed:
21
4
2022
medline:
21
4
2022
entrez:
20
4
2022
Statut:
epublish
Résumé
SARS-CoV-2 infection of the upper airway and the subsequent immune response are early, critical factors in COVID-19 pathogenesis. By studying infection of human biopsies in vitro and in a hamster model in vivo, we demonstrated a transition in tropism from olfactory to respiratory epithelium as the virus evolved. Analyzing each variants revealed that SARS-CoV-2 WA1 or Delta infects a proportion of olfactory neurons in addition to the primary target sustentacular cells. The Delta variant possesses broader cellular invasion capacity into the submucosa, while Omicron displays longer retention in the sinonasal epithelium. The olfactory neuronal infection by WA1 and the subsequent olfactory bulb transport via axon is more pronounced in younger hosts. In addition, the observed viral clearance delay and phagocytic dysfunction in aged olfactory mucosa is accompanied by a decline of phagocytosis related genes. Furthermore, robust basal stem cell activation contributes to neuroepithelial regeneration and restores ACE2 expression post-infection. Together, our study characterized the nasal tropism of SARS-CoV-2 strains, immune clearance, and regeneration post infection. The shifting characteristics of viral infection at the airway portal provides insight into the variability of COVID-19 clinical features and may suggest differing strategies for early local intervention.
Identifiants
pubmed: 35441175
doi: 10.1101/2022.04.12.487379
pmc: PMC9016639
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI132590
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143731
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC016106
Pays : United States
Déclaration de conflit d'intérêts
Competing interests: The authors declare no competing interests.